Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for FDMT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 84.96M
March 31, 2026 61.07M
December 31, 2025 61.05M
September 30, 2025 55.00M
June 30, 2025 52.75M
March 31, 2025 46.01M
December 31, 2024 49.78M
September 30, 2024 51.08M
June 30, 2024 31.78M
March 31, 2024 29.32M
December 31, 2023
September 30, 2023 31.68M
June 30, 2023 27.36M
March 31, 2023 25.42M
Date Value
December 31, 2022 30.51M
September 30, 2022 28.72M
June 30, 2022 30.42M
March 31, 2022 28.87M
December 31, 2021 34.38M
September 30, 2021 16.48M
June 30, 2021 14.29M
March 31, 2021 27.68M
December 31, 2020
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019 28.22M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Amgen, Inc. 83.95B
AnaptysBio, Inc. 316.94M
Precision BioSciences, Inc. 80.63M
Design Therapeutics, Inc. 13.27M
Inhibrx Biosciences, Inc. 207.20M

Total Liabilities (Quarterly) Related Metrics